Neurodegenerative disorders, such as Alzheimer’s disease (AD) or Parkinson’s disease (PD), are accompanied by the loss of specific neurons and alterations in the conformation of proteins such as β-amyloid and tau (in AD) and α-synuclein (in PD). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.